논문KCI 등재
The Authors Reply: Reply on “Evidence Is Enough?: A Systematic Review and Network Meta-Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients”
대한배뇨장애요실금학회 (Korean Continence Society)|2017.09|International Neurourology Journal|제21권 제3호|pp. 231-232
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
.
Abstract
.
참고문헌 (4)
- 김수진, "Evidence Is Enough?: A Systematic Review and Network Meta- Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients", International Neurourology Journal, 21(1), pp.29~37 (2017), 대한배뇨장애요실금학회
- Choi H, "Assessment of tamsulosin 0.2 mg for symptomatic bladder outlet obstruction secondary to benign prostatic enlargement: data from a Korean multicenter cross-sectional study", Urol Int, 95, pp.50~55 (2015)
- Kim KS, "Efficacy of dose escalation of tamsulosin for the treatment in symptomatic benign prostatic hyperplasia of lower urinary tract symptoms:a randomised, double-blind, phase 3 trial in Korean men", J Urol, 195(4 Suppl), pp.e466~ (2016)
- 태범식, "Letter to the Editor: Commentary on “Evidence Is Enough?: A Systematic Review and Network Meta-Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients”", International Neurourology Journal, 21(3), pp.229~230 (2017), 대한배뇨장애요실금학회
관련 논문AI추천
Letter to the Editor: Commentary on “Evidence Is Enough?: A Systematic Review and Network Meta-Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients”최훈, 배재현, 태범식대한배뇨장애요실금학회 · International Neurourology Journal2017 · 제21권 제3호Evidence Is Enough?: A Systematic Review and Network Meta- Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients김수진, 김준철, 김진욱, 신인수, 은성종, 조영삼, 황보택근대한배뇨장애요실금학회 · International Neurourology Journal2017 · 제21권 제1호Beta 3 Adrenoreceptor Agonist for the Management of Lower Urinary Tract Symptoms in Men With Benign Prostatic Hyperplasia: A Systematic Review강태욱, 김명하, 김수진, 정재흥대한배뇨장애요실금학회 · International Neurourology Journal2021 · 제25권 제3호Commentary on “Changes in Prevalence and Treatment Pattern of Benign Prostatic Hyperplasia in Korea”감성철, 신유섭, 이기수대한배뇨장애요실금학회 · International Neurourology Journal2021 · 제25권 제4호Reply to Commentary on “Changes in Prevalence and Treatment Pattern of Benign Prostatic Hyperplasia in Korea”김규식, 문홍상, 신성호, 조정기대한배뇨장애요실금학회 · International Neurourology Journal2021 · 제25권 제4호남성 하부요로증상 환자에서 전립선 크기가Tamsulosin의 효과에 미치는 영향김대경, 배재현, 이정구대한배뇨장애요실금학회 · International Neurourology Journal2007 · 제11권 제1호
이 간행물의 다른 논문 (11건)
Fine Particulate Matter and Urology: Emphasis on the Lower Urinary Tract김진욱pp. 153-154Particulate Matter (Fine Particle) and Urologic Diseases김은아pp. 155-162Comparison of 5 Different Rat Models to Establish a Standard Animal Model for Research Into Interstitial Cystitis권태균, 유은상, 송필현, 이준녕, 정재욱, 전소영, 이효정, 김범수, 김대환, 하윤석, 김연용, 김정식pp. 163-170Potential Biomarkers for Diagnosis of Overactive Bladder Patients: Urinary Nerve Growth Factor, Prostaglandin E2, and Adenosine Triphosphate조원진, 이효석, 이문재, 이규성, 성현환, 고광진, 김태헌, 서윤석pp. 171-177Afferent Pathway-Mediated Effect of α1 Adrenergic Antagonist, Tamsulosin, on the Neurogenic Bladder After Spianl Cord Injury한진희, 고일규, 김성은, 김계환, 김자영pp. 178-188
